Holen Sie sich die Stockscreener-App
0.64
1.54%
-0.01
Schlusskurs vom Vortag:
$0.65
Offen:
$0.65
24-Stunden-Volumen:
28,190
Relative Volume:
0.19
Marktkapitalisierung:
$33.96M
Einnahmen:
$20.59M
Nettoeinkommen (Verlust:
$24.31M
KGV:
1.28
EPS:
0.5
Netto-Cashflow:
$-44.02M
1W Leistung:
-9.39%
1M Leistung:
-37.25%
6M Leistung:
-45.30%
1J Leistung:
-53.96%
1-Tages-Spanne:
$0.6306
$0.6655
1-Wochen-Bereich:
$0.6306
$0.71
52-Wochen-Spanne:
$0.6306
$1.436
Enzo Biochem Inc Stock (ENZ) Company Profile
Firmenname
Enzo Biochem Inc
Sektor
Branche
Telefon
(516) 755-5500
Adresse
60 EXECUTIVE BLVD, FARMINGDALE, NY
Vergleichen Sie ENZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.6424 | 33.96M | 20.59M | 24.31M | -44.02M | 0.50 |
|
TMO
Thermo Fisher Scientific Inc
|
560.58 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
240.66 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
145.46 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
198.32 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
427.98 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2011-10-18 | Bestätigt | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | Eingeleitet | Lazard Capital | Buy |
Enzo Biochem Inc Aktie (ENZ) Neueste Nachrichten
Enzo Biochem Receives Notice from NYSE Regarding Listing ComplianceFarmingdale, NY – Enzo Biochem, Inc. (NYSE: ENZ) recently disclosed that it received a notice from the New York Stock Exchange (NYSE) indicating non-compliance with certain listing - Defense World
Enzo Biochem faces NYSE compliance challenges By Investing.com - Investing.com Canada
Enzo Biochem Faces NYSE Compliance Challenges - TipRanks
Enzo Biochem faces NYSE compliance challenges - Investing.com India
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - The Manila Times
Enzo Biochem Receives NYSE Non-Compliance Notice Over Market Cap and Share Price Issues - StockTitan
ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges - MSN
Enzo Biochem (NYSE:ENZ) versus Grail (NASDAQ:GRAL) Financial Review - Defense World
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.68 amid challenges - Investing.com Nigeria
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Enzo Biochem (ENZ) Stock Surges 5.19% Amid Market Activity - GuruFocus.com
Enzo Biochem, Inc.'s (NYSE:ENZ) 33% Share Price Plunge Could Signal Some Risk - Simply Wall St
Enzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024) - Yahoo Finance
Enzo Biochem stock hits 52-week low at $0.92 amid challenges - Investing.com
Enzo Biochem: Fiscal Q1 Earnings Snapshot - Midland Daily News
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - MarketBeat
Enzo Biochem, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2024 - Marketscreener.com
Enzo Biochem Reports Narrowed Loss Amid Revenue Decline - TipRanks
ENZEnzo Biochem, Inc. Latest Stock News & Market Updates - StockTitan
Enzo Biochem (NYSE:ENZ) Announces Quarterly Earnings Results - MarketBeat
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update - GlobeNewswire
Enzo Biochem Reports 20% Revenue Drop Amid Life Sciences Slowdown; Maintains $47.7M Cash Position - StockTitan
The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem - Yahoo Finance
Top Stock Reports for Amgen, Eaton & Enzo Biochem - Yahoo Finance
US Penny Stocks To Watch In December 2024 - Simply Wall St
Enzo Biochem, Inc. (NYSE:ENZ) Sees Large Drop in Short Interest - MarketBeat
Flow Cytometer Market to Expand by USD 8.17 Billion (2024-2028), Rising R&D Investments Drive Growth, Report on AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Enzo Biochem Appoints Jon Couchman to Board - TipRanks
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - MarketBeat
Enzo Biochem stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem stock hits 52-week low at $0.99 amid market challenges - Investing.com Canada
Oxidative Stress Assay Market Geographical Segmentation, - openPR
Will Enzo Biochem (NYSE:ENZ) Spend Its Cash Wisely? - Simply Wall St
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate - Yahoo Finance
Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023) - Yahoo Finance UK
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands - MSN
Finanzdaten der Enzo Biochem Inc-Aktie (ENZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):